NMR backbone dynamics of the human type I interferon binding subunit, a representative cytokine receptor.
The antiviral and antiproliferative activities of type I interferons (IFNs) are mediated by a common receptor, and its second subunit (IFNAR2) exhibits nanomolar affinity to both IFNalpha and IFNbeta subtypes. We have previously determined the structure of the IFN-binding extracellular domain of IFNAR2 (IFNAR2-EC) using multidimensional NMR [Chill, J. H., Quadt, S. R., Levy, R., Schreiber, G. E., and Anglister, J. (2003) Structure 11, 791-802], showing it to comprise two fibronectin domains linked by a hinge. As the first cytokine receptor structure determined in the unliganded state and in solution, IFNAR2-EC offers an opportunity to characterize the dynamics of the cytokine receptor family and their correlation to biological function. Backbone dynamics of IFNAR2-EC were investigated using 15N relaxation at 11.74 and 18.79 T, and measurements of residual dipolar couplings (RDCs). Dynamics of the binding site distinguish between rigid structural domains, which stabilize the binding site conformation, and a more flexible binding interface which interacts with the ligand. Measurements of diffusional anisotropy and RDCs and model-free analysis all show that the backbone of the hinge interdomain region of IFNAR2-EC is rigid on the picosecond to nanosecond time scale. Signal transduction in cytokines receptors is initiated by ligand-induced juxtaposition of the two receptor subunits, triggering the mutual phosphorylation of kinases associated to their cytoplasmic domains. The rigidity of the hinge ensures correct positioning of the receptor subunits in the ternary signaling complex and modulates the interaction between kinases in the cytoplasm, thereby controlling the rate and efficiency of phosphorylation.
Department of Structural Biology, Weizmann Institute of Science, Rehovot 76100, Israel. jordan.chill@weizmann.ac.il
Jordan H
JH
Chill
Sabine R
SR
Quadt
Jacob
J
Anglister
D016880:Anisotropy; D001665:Binding Sites; D005110:Extracellular Space / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D007370:Interferon Type I / Q000737:chemistry / Q000378:metabolism*; D008565:Membrane Proteins; D008956:Models, Chemical; D009587:Nitrogen Isotopes / Q000378:metabolism; D019906:Nuclear Magnetic Resonance, Biomolecular / Q000379:methods; D010446:Peptide Fragments / Q000737:chemistry / Q000378:metabolism; D011485:Protein Binding; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D021122:Protein Subunits / Q000737:chemistry / Q000378:metabolism*; D011522:Protons; D053633:Receptor, Interferon alpha-beta; D017471:Receptors, Interferon / Q000737:chemistry* / Q000378:metabolism*; D013816:Thermodynamics
C508033:IFNAR2 protein, human; D007370:Interferon Type I; D008565:Membrane Proteins; D009587:Nitrogen Isotopes; D010446:Peptide Fragments; D021122:Protein Subunits; D011522:Protons; D017471:Receptors, Interferon; D053633:Receptor, Interferon alpha-beta